Books in Drug adverse reactions and interactions

21-30 of 31 results in All results

Histopathology of Preclinical Toxicity Studies

• 4th Edition
• October 7, 2011
• Peter Greaves
• English
• Hardback 978-0-444-53856-7

  9 7 8 - 0 - 4 4 4 - 5 3 8 5 6 - 7

The new 4th edition of Histopathology of Preclinical Toxicity Studies is now completely in full color and continues to describe the pathology found in drug safety studies in laboratory animals with an evidence-based discussion of the relevance of these findings to the clinical investigation of new drugs for humans. Organized according to organ systems, this revision features a thoroughly updated bibliography and discusses new drug-induced pathologies and applicable species comparisons to aid in the preclinical safety assessment of new medicines. This updated reference is essential for those involved in drug safety evaluation, including pathologists, toxicologists and pharmacologists working in corporate, government, academic and research settings.

Meyler's Side Effects of Drugs in Cancer and Immunology

• 1st Edition
• April 19, 2010
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53267-1

  9 7 8 - 0 - 4 4 4 - 5 3 2 6 7 - 1
• eBook 978-0-08-093288-0

  9 7 8 - 0 - 0 8 - 0 9 3 2 8 8 - 0

Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.

Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs

• 1st Edition
• December 16, 2009
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53273-2

  9 7 8 - 0 - 4 4 4 - 5 3 2 7 3 - 2
• eBook 978-0-08-093294-1

  9 7 8 - 0 - 0 8 - 0 9 3 2 9 4 - 1

Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. Opioids and analgesics are members of a diverse group of drugs used to relieve pain. They are frequently used in combination with prescription and nonprescription pain relievers, and misuse is prevalent. Pain medicine specialists and physicians or surgeons will find this volume useful in prescribing the appropriate drugs for pain therapy and for preventing misuse of the medication.

Meyler's Side Effects of Antimicrobial Drugs

• 1st Edition
• November 25, 2009
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53272-5

  9 7 8 - 0 - 4 4 4 - 5 3 2 7 2 - 5
• eBook 978-0-08-093293-4

  9 7 8 - 0 - 0 8 - 0 9 3 2 9 3 - 4

Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. This volume is essential for internal medicine physicians and general practitioners who prescribe antibiotic drugs, like penicillin and tetracycline that cure bacterial infections, and antiviral drugs used to treat patients with HIV and herpes viruses.

Meyler's Side Effects of Endocrine and Metabolic Drugs

• 1st Edition
• January 20, 2009
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53271-8

  9 7 8 - 0 - 4 4 4 - 5 3 2 7 1 - 8
• eBook 978-0-08-093292-7

  9 7 8 - 0 - 0 8 - 0 9 3 2 9 2 - 7

Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Endocrine and metabolic diseases are common, includes diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary care practitioners, obstetricians and gynecologists, and others will find this book useful when treating endocrine or metabolic diseases.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of endocrine and metabolics mediations.

Meyler's Side Effects of Psychiatric Drugs

• 1st Edition
• October 10, 2008
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53266-4

  9 7 8 - 0 - 4 4 4 - 5 3 2 6 6 - 4
• eBook 978-0-08-093287-3

  9 7 8 - 0 - 0 8 - 0 9 3 2 8 7 - 3

Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of psychiatric mediations.

Meyler's Side Effects of Herbal Medicines

• 1st Edition
• September 23, 2008
• Jeffrey K. Aronson
• English
• Hardback 978-0-444-53269-5

  9 7 8 - 0 - 4 4 4 - 5 3 2 6 9 - 5
• eBook 978-0-08-093290-3

  9 7 8 - 0 - 0 8 - 0 9 3 2 9 0 - 3

Meyler's Side Effects of Herbal Medicines, named to Doody's Core Titles for 2013, is a derivatrive work based on the acclaimed Meyler’s Side Effect of Drugs, Fifteenth Edition. This book summarizes the adverse effects of a large range of herbal medicines and the active ingredients that they contain. It includes extensive lists of the families of plants that are used as herbal medicines, including the Latin names of genera and species as well as the common names of individual plants. It features not only herbal medicines but information on important compounds such as tropane alkaloids, cardiac glycosides, nicotine, and pyrolizidine alkaloids. The book is divided into three separate sections: Family – Each monograph is organized under a family of plants (for example, Liliaceae) Genera – The various genera that are included under the family name are tabulated (for example, the family Liliaceae contains 94 genera) Species – In each monograph, some species are dealt with separately (for example, in Liliaceae, four species are included under their Latin names and major common names) Each monograph includes the following information: Alternative common names Active ingredients Uses – both traditional and modern Adverse effects References Drug names are designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names or brand names are used. The material is drawn from the fifteenth edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. This volume is critical for any health professional or homeopathic practitioner with an interest in herbal medicines.

Side Effects of Drugs Annual

• 1st Edition
• Volume 28
• November 29, 2005
• Jeffrey K. Aronson
• English
• eBook 978-0-08-045950-9

  9 7 8 - 0 - 0 8 - 0 4 5 9 5 0 - 9

Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier.com/locate/series/seda) continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction. The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.

Side Effects of Drugs Annual

• 1st Edition
• Volume 26
• August 22, 2003
• Jeffrey K Aronson
• English
• eBook 978-0-08-052280-7

  9 7 8 - 0 - 0 8 - 0 5 2 2 8 0 - 7

The Side Effects of Drugs Annual was first published in 1977. It has been published continuously since then, as a yearly update to the encyclopaedic volume Meyler's Side Effects of Drugs. Each new Annual provides clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists have contributed to the Annuals by selecting critically from each year's publications all that is truly new and informative, by critically interpreting it, and by pointing out whatever is misleading. The use of the book is enhanced by separate indexes, allowing the reader to enter the text via the drug name, adverse effect, or drug interaction.Special features of the Annuals are the Side Effects of Drugs Essay, usually written by a guest author, and the special reviews: short articles, within the different chapters, that give extra attention to topics of current interest.The Essay in Annual 26 is entitled 'How safe is cannabis?' (by Professor L.L. Iversen) and there is a Historical Essay entitled 'From thalidomide to pharmacovigilance: a personal account' (by Professor D.J. Finney).The special reviews in this volume include, among others: The cognitive effects of Ecstasy Antipsychotic drugs and weight gain Vigabatrin-related visual abnormalities Managing the adverse effects of morphine The cardiotoxic effects of antihistamines Inhaled corticosteroids and growth inhibition in children Bioterrorism and its prevention through immunization

A Manual of Adverse Drug Interactions

• 5th Edition
• November 17, 1997
• J.P. Griffin + 1 more
• English
• eBook 978-0-08-052583-9

  9 7 8 - 0 - 0 8 - 0 5 2 5 8 3 - 9

For twenty years this book, now in its 5th edition, has provided information on adverse drug interactions that is unrivalled in coverage and scholarship.Adverse drug reactions, many of them ascribable to interactions with other drugs or with chemical substances in food or the environment, are thought to cause or complicate one in twenty of hospital admissions.The book is conveniently divided into two parts: Part 1 comments on drug interactions and their mechanisms, on a pharmacokinetic and pharmacodynamic level, while Part 2 consists of drug interaction tables, divided and subdivided into categories of disorders, and the drugs used in the treatment of these disorders.If safety in drugs is to improve, education of prescribers is vitally important. This book, with its up-to-date and coordinated approach, serves that purpose well. The real threat, as the authors remind us, is the ignorance of practitioners, not the drug itself. The volume is therefore an essential addition to the shelves of those responsible for the prescription of drugs, in order to prevent a potential backlash when used in combination with other drugs or chemical substances.